|Bid||10.60 x 0|
|Ask||10.62 x 0|
|Day's Range||10.58 - 11.20|
|52 Week Range||4.55 - 24.75|
|PE Ratio (TTM)||50.72|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.08|
Aphria Inc. (TSX:APH) and Maple Leaf Foods Inc. (TSX:MFI) stocks have struggled in 2018 but both could be great buys in the spring.
Cronos Group Inc. (TSXV:CRON)(NASDAQ:CRON) and MedReleaf Corp. (TSX:LEAF) each offer interesting and unique angles on how to play the marijuana sector. Find out what they are.
Here's why Canopy Growth Corp. (TSX:WEED) is the best long-term cannabis stock to own.
Marijuana stocks are down to start 2018, as the expected date for the drug to become legal has suffered a delay. Find out what it means for stocks like Canopy Growth Corp. (TSX:WEED) and two others.
Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company that Scythian is in the process of acquiring, has received its first purchase order (the “Order”) of CBD oil, which is to be fulfilled under the supply agreement with Aphria Inc. (APH.TO) (“Aphria”), a prominent Canadian producer of medical cannabis. The Order is for Aphria’s renowned CBD oil strain, Rideau.
Aurora Cannabis Inc. (TSX:ACB) beefs up its capacity with Aurora Sun. Could the stock be heading for another parabolic surge?
Aphria Inc. (TSX:APH) stock continues to price in very optimistic expectations, while its earnings results are not so impressive.
LEAMINGTON, ON, April 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today introduced its first brand designed for Canada's new adult-use market, Solei Sungrown Cannabis ("Solei"). Solei has been designed to demystify cannabis and will enable current and novice users alike to control and enrich their cannabis journey, pairing an assortment of carefully curated products and strains with different experiences. Solei was created specifically for what will be one of the largest segments in the Canadian cannabis landscape, defined not by age, gender or geography, but rather by a shared mindset and attitude.
Shares of licensed medical marijuana producer Aphria Inc. surged Monday on better than expected quarterly results and after news of a changing political tone on cannabis south of the border. Aphria reported a $12.9-million profit in its fiscal third quarter, boosted by the sale of some of its shares in U.S. company Liberty Health Sciences, and reduced production costs per gram of cannabis. The Leamington, Ont.-based producer's stock rose as much as 8.95 per cent the Toronto Stock Exchange on Monday, before closing at $12.24, up 7.37 per cent.
Tenth consecutive quarter of positive adjusted EBITDA 2 Significant levels of cash available for deployment in attractive investment opportunities LEAMINGTON, ON , April 16, 2018 /CNW/ - Aphria Inc. (" ...
Cannabis Growth Corp. (TSX:WEED), Aurora Cannabis Inc. (TSX:ACB), and Aphria Inc. (TSX:APH) are all trading significantly lower than their highs, but fundamentals and valuations still do not support buying at this time.
Aphria Inc. (TSX:APH) has been struggling mightily this year, and it needs a good earnings report to pull itself out from the abyss.
While Canadian pot stocks beat the market by a wide margin last year, they are underperforming year-to-date. Aphria Inc. (TSX:APH) has been particularly hit.
Aurora Cannabis Inc. (TSX:ACB), Canopy Growth Corp. (TSX:WEED), and other pot stocks could be in for a disastrous end to 2018. Here's why investors should cash out on cannabis stocks while they still can.
Aphria Inc. (TSX:APH) is down big to start the year, but you shouldn't expect it to stay that way for much longer.
Top growth stocks like Dollarama Inc. (TSX:DOL) have been battered along with the broader Canadian stock market to start 2018.
Cannabis stocks are undergoing a correction. Will valuation rebounds for Aurora Cannabis Inc. (TSX:ACB) and other players outperform the TSX?
LEAMINGTON, ON, April 10, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its third quarter results for 2018 on April 16, 2018. Financial results are expected to be released at approximately 7:00am ET, through SEDAR and on Aphria's website at www.aphria.ca/investors. A conference call is scheduled for 9:00am ET and will feature a presentation by Aphria executives followed by a question and answer period with analysts.
Canopy Growth Corp. (TSX:WEED) and Aphria Inc. (TSX:APH) are selling off. Is this a buy-the-dip opportunity before the next leg up? Or could the entire industry be a bubble on the verge of popping?